AAAAAA

   
Results: 1-8 |
Results: 8
THE ARIC POSTPRANDIAL STUDY - RELATION OF FACTOR-VII WITH VII-GENE POLYMORPHISM AND TRIGLYCERIDE LEVELS IN CAROTID ATHEROSCLEROSIS CASES AND
Authors: GHADDAR HM ALEKSIC N HEARNE LB FOLSOM AR CHAMBLESS LE MORRISSEY JH
Citation: Hm. Ghaddar et al., THE ARIC POSTPRANDIAL STUDY - RELATION OF FACTOR-VII WITH VII-GENE POLYMORPHISM AND TRIGLYCERIDE LEVELS IN CAROTID ATHEROSCLEROSIS CASES AND, Thrombosis and haemostasis, 1997, pp. 1684-1684
AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA
Authors: GHADDAR HM PIERCE S KANTARJIAN HM FREIREICH EJ KEATING MJ ESTEY EH
Citation: Hm. Ghaddar et al., AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 71-76
FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST
Authors: ANDERLINI P GHADDAR HM SMITH TL PIERCE S KANTARJIAN HM OBRIEN S KEATING MJ FREIREICH EJ ESTEY EH
Citation: P. Anderlini et al., FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST, Leukemia, 10(6), 1996, pp. 964-969
A COMPARISON OF AZTREONAM PLUS VANCOMYCIN AND IMIPENEM PLUS VANCOMYCIN AS INITIAL THERAPY FOR FEBRILE NEUTROPENIC CANCER-PATIENTS
Authors: RAAD II WHIMBEY EE ROLSTON KVI ABISAID D HACHEM RY PANDYA RG GHADDAR HM KARL CL BODEY GP
Citation: Ii. Raad et al., A COMPARISON OF AZTREONAM PLUS VANCOMYCIN AND IMIPENEM PLUS VANCOMYCIN AS INITIAL THERAPY FOR FEBRILE NEUTROPENIC CANCER-PATIENTS, Cancer, 77(7), 1996, pp. 1386-1394
PROGNOSTIC VALUE OF RESIDUAL NORMAL METAPHASES IN ACUTE MYELOGENOUS LEUKEMIA PATIENTS PRESENTING WITH ABNORMAL KARYOTYPE
Authors: GHADDAR HM PIERCE S REED P ESTEY EH
Citation: Hm. Ghaddar et al., PROGNOSTIC VALUE OF RESIDUAL NORMAL METAPHASES IN ACUTE MYELOGENOUS LEUKEMIA PATIENTS PRESENTING WITH ABNORMAL KARYOTYPE, Leukemia, 9(5), 1995, pp. 779-782
CORRELATION OF SPECIFIC PLATELET ACTIVATION MARKERS WITH CAROTID ARTERIAL-WALL THICKNESS
Authors: GHADDAR HM CORTES J SALOMAA V KARK JD DAVIS CE FOLSOM AR HEISS G STINSON V WU KK
Citation: Hm. Ghaddar et al., CORRELATION OF SPECIFIC PLATELET ACTIVATION MARKERS WITH CAROTID ARTERIAL-WALL THICKNESS, Thrombosis and haemostasis, 74(3), 1995, pp. 943-948
LONG-TERM RESULTS FOLLOWING TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE
Authors: GHADDAR HM PLUNKETT W KANTARJIAN HM PIERCE S FREIREICH EJ KEATING MJ ESTEY EH
Citation: Hm. Ghaddar et al., LONG-TERM RESULTS FOLLOWING TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE, Leukemia, 8(8), 1994, pp. 1269-1274
CYTOGENETIC EVOLUTION FOLLOWING THE TRANSFORMATION OF MYELODYSPLASTIC-SYNDROME TO ACUTE MYELOGENOUS LEUKEMIA - IMPLICATIONS ON THE OVERLAP BETWEEN THE 2 DISEASES
Authors: GHADDAR HM STASS SA PIERCE S ESTEY EH
Citation: Hm. Ghaddar et al., CYTOGENETIC EVOLUTION FOLLOWING THE TRANSFORMATION OF MYELODYSPLASTIC-SYNDROME TO ACUTE MYELOGENOUS LEUKEMIA - IMPLICATIONS ON THE OVERLAP BETWEEN THE 2 DISEASES, Leukemia, 8(10), 1994, pp. 1649-1653
Risultati: 1-8 |